Wednesday January 25, 2012

Scientists at the Gladstone Institutes, an independent and nonprofit biomedical-research organization, have identified a protein that exacerbates symptoms of Parkinson's disease—a discovery that could one day lead to new treatments for people who suffer from this devastating neurodegenerative illness.

Monday January 23, 2012

Monday January 23, 2012

Recent studies have found statistical links between pesticide use and an outbreak of Parkinson's disease in California farm towns. Researchers even know which chemicals are the likely culprits. What's the government doing about it?

Monday January 23, 2012

A decade or so ago, psychiatrists would have been hard pressed to provide evidence-based psychiatric treatments to Parkinson’s patients. Thanks to research advances, that situation has improved considerably.

Monday January 23, 2012

UNNYVALE, Calif. & THE WOODLANDS, Texas, Jan 23, 2012 (BUSINESS WIRE) -- Amarantus BioSciences, Inc. AMBS , a biotechnology company developing MANF, a first-in-class disease--modifying therapeutic protein being developed for the treatment of Parkinson's Disease, today announced an exclusive worldwide license agreement with Power3 Medical Products, Inc. for the NuroPro(R) Blood Test as it relates to Parkinson's disease diagnosis. Concurrent with the license, Amarantus has raised $100,000 from a private, foreign investor introduced to the Company by www.tomorrowsbluechips.com .

Tuesday January 17, 2012

Tuesday January 17, 2012

In the living room of a lovely home at the end of an oak tree-lined lane in Hillsboro, Ore., Ben Petrick inserts a disc into the DVD player. His wife, Kellie, has taken their 4-year-old daughter, Makena, upstairs for a nap, giving Petrick the opportunity to flop into his easy chair and fast-forward to the moment he wants you to see.